Liposomal-Naringenin Radiosensitizes Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro
Background. Naringenin has shown great promise in the realm of cancer therapeutics, demonstrating excellent cytotoxic action toward cancer cells and the enhanced effects of radiation therapy in vitro. However, the medicinal value of naringenin is severely limited clinically by poor bioavailability....
Saved in:
| Main Authors: | Keenau Pearce, Samantha I. Cairncross, Mongi Benjeddou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | IET Nanobiotechnology |
| Online Access: | http://dx.doi.org/10.1049/2024/3786627 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MDA-MB-231 cell apoptosis in vitro induced by dihydromyricetin
by: ZHOU Fang-zhen, et al.
Published: (2012-05-01) -
Intraline genomic heterogeneity of the triple-negative breast cancer MDA-MB-231-luc-GFP cell line
by: Nair Varela-Rouco, et al.
Published: (2025-01-01) -
The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells.
by: Imaobong Christopher Etti, et al.
Published: (2017-01-01) -
Effects of Pharmacological Dose of Vitamin C on MDA-MB-231 Cells
by: Lunawati Lo Bennett
Published: (2025-03-01) -
SIRT2 Inhibition by AGK2 Promotes Perinuclear Cytoskeletal Organisation and Reduces Invasiveness of MDA-MB-231 Triple-Negative Breast Cancer Cells in Confined In Vitro Models
by: Emily Jessop, et al.
Published: (2024-12-01)